WHO IRIS
open access
Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- From Laboratory to Patient Access: A Scoping Review of the Multi-Dimensional Challenges in Drug Repurposing.#317784
- TubeClear® Evaluation in Pediatric Patients (Phase I)#1072669
- A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder#1087273
- 22 U.S.C. § 2291j-1 — International drug control certification procedures#579543
- Efficacy and Safety of Bifidobacterium Quadruple Live Tablets in Patients With T2DM and Constipation#154838
Record · ID 660643
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive